… and international recommendations to guide lipid management in Asian patients with type 2 diabetes with special reference to renal dysfunction: 对亚洲2 型糖尿病患者 …
… The role and pathogenesis of dyslipidemia in CKD are still not … Furthermore, hyperlipidemia
could worsen inflammation of … concerns about potential renal adverse effects of some statins, …
could worsen inflammation of … concerns about potential renal adverse effects of some statins, …
… (加味苓桂术甘汤) Ameliorates Glycolipid Metabolism and Inflammation via PI3K-Akt/mTOR-S6K1/AMPK-PGC-1 α Signaling Pathways in Obese Type 2 Diabetic Rats
J Sun, L Shi, F Wang, J Qin, B Ke - Chinese journal of integrative medicine, 2020 - Springer
… high-fat and STZinduced obese diabetic rats. The results … effects were enhanced with the
increasing dose of MLZD. Obesity-induced diabetes is always associated with hyperlipidemia. …
increasing dose of MLZD. Obesity-induced diabetes is always associated with hyperlipidemia. …
Salivary interleukin‐17 and tumor necrosis factor‐α in relation to periodontitis and glycemic status in type 2 diabetes mellitus: 2型糖尿病患者唾液中的白细胞介素‐17以及肿瘤坏死 …
… Hyperglycemia and hyperlipidemia in T2DM affect several pathways, such as the aldose
reduction pathway, advanced glycation end pathway, and reactive oxygen intermediate …
reduction pathway, advanced glycation end pathway, and reactive oxygen intermediate …
Type 2 diabetes mellitus‐related genetic polymorphisms in microRNAs and microRNA target sites (MicroRNAs 中与2 型糖尿病相关的基因多态性及microRNA 靶位)
W Gong, D Xiao, G Ming, J Yin, H Zhou… - … of Diabetes, 2014 - Wiley Online Library
… Dyslipidemia associated with T2DM is characterized by high levels of plasma triglycerides
(TG), very low-density lipoprotein (VLDL) and low levels of high-density lipoprotein (HDL).52 …
(TG), very low-density lipoprotein (VLDL) and low levels of high-density lipoprotein (HDL).52 …
… associated with peripheral arterial disease in women, but not men, with type 2 diabetes mellitus: 血清脂肪细胞型脂肪酸结合蛋白水平与女性而不是男性2 型糖尿病患者 …
M Ding, JY Shi, YZ XING, B Sun, QH Fang… - … of Diabetes, 2018 - Wiley Online Library
… The relationship between A-FABP and metabolic factors, including insulin resistance,
dyslipidemia, and glucose tolerance, may explain the effects of A-FABP on the metabolic …
dyslipidemia, and glucose tolerance, may explain the effects of A-FABP on the metabolic …
… oxygen inhibits the growth‐related decline in skeletal muscle oxidative capacity and prevents hyperglycemia in rats with type 2 diabetes mellitus: 在2 型糖尿病大鼠中 …
F Nagatomo, A Takemura, RR Roy, H Fujino… - … of Diabetes, 2018 - Wiley Online Library
… However, regardless of pressure, oxygen treatments involving more than 40% oxygen have
some adverse effects (eg, erythrocytes are damaged by active oxygen and the binding of …
some adverse effects (eg, erythrocytes are damaged by active oxygen and the binding of …
Brain atrophy in middle‐aged subjects with Type 2 diabetes mellitus, with and without microvascular complications: 合并或者不合并微血管并发症的中年2 型糖尿病受试 …
… , but also with known cardiovascular risk factors, such as increased BMI, hypertension,
and dyslipidemia (as evidenced by the use of statins). These findings imply that, apart from …
and dyslipidemia (as evidenced by the use of statins). These findings imply that, apart from …
… to high‐density lipoprotein cholesterol and incident type 2 diabetes in Singapore Chinese men and women: 三酰甘油与高密度脂蛋白的比例和新发2 型糖尿病的关系 …
… Dyslipidemia, especially increased triglycerides (TG) together … type 2 diabetes (T2D).1
Mechanistic studies suggest that high TG and low HDL-C levels may be causal factors for T2D,2 …
Mechanistic studies suggest that high TG and low HDL-C levels may be causal factors for T2D,2 …
Efficacy and Safety of Evolocumab in Chinese Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia: 12-Week Primary Results of the HUA TUO 华佗 …
H Tan, W Li, Z Huang, Y Han, X Huang, D Li… - Cardiology and …, 2023 - Springer
… kexin type 9 inhibitor antibody, significantly lowers low-density lipoprotein cholesterol (LDL-C)
in patients with type 2 diabetes mellitus and hyperlipidemia and mixed dyslipidemia. This …
in patients with type 2 diabetes mellitus and hyperlipidemia and mixed dyslipidemia. This …
… in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the C leveland C linic: 使用包括二甲双胍在内的双药治疗的2 型 …
S Kannan, KM Pantalone, S Matsuda… - … of diabetes, 2016 - Wiley Online Library
… of type 2 diabetes mellitus (T2DM).1, 2 In patients with inadequate glycemic control with
MF, the ideal choice of the second-line antidiabetic therapy is under debate.3 The Glycemia …
MF, the ideal choice of the second-line antidiabetic therapy is under debate.3 The Glycemia …